These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7356889)

  • 21. Beta blockade in essential hypertension: an analysis of response to oxprenolol.
    Barritt DW; Marshall AJ
    Br Heart J; 1977 Aug; 39(8):825-8. PubMed ID: 901673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).
    Brecht HM; Banthien F; Ernst W; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():485S-488S. PubMed ID: 1071667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxprenolol in hypertension.
    Marshall AJ; Barritt DW
    Br J Clin Pract; 1973 Sep; 27(9):337-40. PubMed ID: 4595073
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once daily dosage beta-blockade: antihypertensive efficacy of slow release oxprenolol as related to renin and age.
    Bühler FR; Lütold BE; Küng M; Koller FJ
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):37-43. PubMed ID: 1071402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxprenolol hydrochloride: a long-term study of efficacy, safety, and tolerability.
    Tarpley EL
    Pharmacotherapy; 1982; 2(5):281-4. PubMed ID: 6820501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once daily administration of a beta-blocker in hypertension.
    Watt M; Duncan TD
    N Z Med J; 1978 Feb; 87(606):126-8. PubMed ID: 274648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oxprenolol and metoprolol on serum lipid concentration.
    Ferrara LA; Marotta T; Scilla A; Mastranzo P; Strazzullo P; Mancini M
    Eur J Clin Pharmacol; 1984; 26(3):331-4. PubMed ID: 6734694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentration and antihypertensive effect of beta-receptor blockers.
    Hitzenberger G
    Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.